FDA Approved: BIMATOPROST — Supplemental Application (Sandoz Inc)

View source ↗

Summary

The FDA approved a supplemental application for bimatoprost submitted by Sandoz Inc, authorizing an addition/adjustment to the product's approval.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• Bimatoprost (bimatoprost)

Snippet

SUPPL AP for BIMATOPROST (BIMATOPROST)